GLP-1 drugs like Ozempic and Wegovy have rapidly moved from niche diabetes treatments to blockbuster weight loss injections, reshaping how doctors and patients think about obesity. As prescriptions ...

Q4 2025 Earnings Call Transcript December 17, 2025 Veru Inc. beats earnings expectations. Reported EPS is $0.05, expectations ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

The test, a cell-free DNA test, uses a sample of the mother's blood to screen for certain conditions in the developing fetus ...

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an accep ...

Bariatric doctors who regularly prescribe GLP-1s share how long the worst Ozempic side effects last, and the best ways to ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

Pharmacies across India will soon feature a QR code and toll-free number to report medicine side effects. This initiative by the CDSCO aims to empower citizens and healthcare professionals to ...

NEW DELHI: The next time you step into a chemist shop, you may find a new addition near the counter — a black-and-white QR code that could quietly transform India’s drug safety system. The Central ...